CM-6325

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCM-6325
Drug Alias NameCM-6325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatitis, ChronicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalcimedica Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalcimedica Inc
Inactive CompaniesN/A
Active IndicationsPancreatitis, ChronicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A